I-many - Know Us By The Company We Keep
Since 1989, I-many has established a following of satisfied clients who continue to implement additional I-many solutions. These customers depend on I-many for mission critical solutions that deliver strong return on investment, enhance business process and provide competitive advantage. Our core asset is our customer base - these customers continue to provide I-many with a long term opportunity for the sale of our ContractSphere products.
I-many's Clientele - Fortune 500 Companies:
- Hundreds of customers worldwide in production with I-many solutions
- Spanning across 21 industries
- Over 25% with non-U.S. deployments
- 25% of Fortune 50 companies
- More than 70% with over $1B in revenue
- 10 of the Top 10 Pharmaceutical companies use I-many solutions
- 23 of the Top 25 Pharmaceutical companies use I-many solutions
- 18 of the Top 25 Pharmaceutical companies use I-many Medicaid
- 16 of the Top 25 Pharmaceutical companies use I-many CARS
- 13 of the Top 25 Pharmaceutical companies use I-many Government Pricing
- 300+ projects in 6 years
- 200+ integrations with SAP, PeopleSoft, Oracle, and other legacy systems
Featured Customers
|
|
"The I-many Enterprise Contract Management solution is an important element of our drive to achieve functional excellence in contracting."
|
|
|
"Rebates are a huge part of RONA's business and result in significant financial exposure. We looked at virtually every major software provider and I-many was the only company with a proven rebate management solution that can help validate rebates against the contracts that govern them. We believe I-many CARS/RM will help dramatically reduce our rebate management processing time in a very short period of time and provide a significant return on investment."
|
|
|
"The capacity to track detailed contract terms and payments, and process Medicaid rebates is of vital importance to our company. I-many's strong domain expertise, its 15 years of experience in the Life Sciences industry and the unparalleled capabilities of its products made them an obvious choice for Wockhardt."
|



